Professor of Pediatrics, Harvard Medical School Senior Physician in Medicine, Boston Children's Hospital
Pediatric Infectious Disease
Dr. Robert N. Husson, MD
|
|
Give Review
Robert Husson is an expert in the field of Pediatric Infectious Disease. He went to Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1 in research and 12 in primary care medicine Robert Husson has written publications. He has 69 publications published with PubMed. The lastest publication is: 'In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria.'
Publications
- tRNA is a new target for cleavage by a MazF toxin.
- Mycobacterium tuberculosis Serine/Threonine Protein Kinases.
- Mycobacterial Gene cuvA Is Required for Optimal Nutrient Utilization and Virulence.
- Phosphorylation regulates mycobacterial proteasome.
- Mycobacterial toxin MazF-mt6 inhibits translation through cleavage of 23S rRNA at the ribosomal A site.
- Using bacteria to determine protein kinase specificity and predict target substrates.
- The Extracytoplasmic Domain of the Mycobacterium tuberculosis Ser/Thr Kinase PknB Binds Specific Muropeptides and Is Required for PknB Localization.
- Extensive phosphorylation with overlapping specificity by Mycobacterium tuberculosis serine/threonine protein kinases.
- Regulation of the SigH stress response regulon by an essential protein kinase in Mycobacterium tuberculosis.
- Critical role of a single position in the -35 element for promoter recognition by Mycobacterium tuberculosis SigE and SigH.
- Mycobacterium tuberculosis SigM positively regulates Esx secreted protein and nonribosomal peptide synthetase genes and down regulates virulence-associated surface lip...
- The Mycobacterium tuberculosis extracytoplasmic-function sigma factor SigL regulates polyketide synthases and secreted or membrane proteins and is required for virulence.
- The Mycobacterium tuberculosis serine/threonine kinases PknA and PknB: substrate identification and regulation of cell shape.
- Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine...
- Transcription regulation by the Mycobacterium tuberculosis alternative sigma factor SigD and its role in virulence.
- Development of a model of focal pneumococcal pneumonia in young rats.
- Cloning and direct examination of a structurally abnormal human beta 0-thalassemia globin gene.
- Tuberculosis prevention in college students.
- Human T cell clones recognize two abundant Mycobacterium tuberculosis protein antigens expressed in Escherichia coli.
- Molecular basis of the defective heat stress response in Mycobacterium leprae.
- Human immunodeficiency virus (HIV) type 1 strain MN neutralizing antibody in HIV-infected children: correlation with clinical status and prognostic value.
- Bacterial infections in human immunodeficiency virus type 1-infected children: the impact of central venous catheters and antiretroviral agents.
- Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection.
- The alternative sigma factor SigH regulates major components of oxidative and heat stress responses in Mycobacterium tuberculosis.
- Novel mycobacterium related to Mycobacterium triplex as a cause of cervical lymphadenitis.
- Related strains of Mycobacterium avium cause disease in children with AIDS and in children with lymphadenitis.
- Nontuberculous mycobacterial infection of the head and neck in immunocompetent children: CT and MR findings.
- Multidrug-resistant tuberculosis meningitis: clinical problems and concentrations of second-line antituberculous medications.
- A mycobacterial extracytoplasmic sigma factor involved in survival following heat shock and oxidative stress.
- Lymphadenitis due to nontuberculous mycobacteria in children: presentation and response to therapy.
- In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria.
- Homologous recombination in Mycobacterium smegmatis. Screening methods for detection of gene replacement.
- Lack of acceptance of guidelines for prevention of disseminated Mycobacterium avium complex infection in infants and children infected with human immunodeficiency virus.
- A mycobacterial extracytoplasmic function sigma factor involved in survival following stress.
- High-level resistance to zidovudine but not to zalcitabine or didanosine in human immunodeficiency virus from children receiving antiretroviral therapy.
- Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.
- The uraA locus and homologous recombination in Mycobacterium bovis BCG.
- Orally administered clarithromycin for the treatment of systemic Mycobacterium avium complex infection in children with acquired immunodeficiency syndrome.
- Pharmacokinetic evaluation of the combination of zidovudine and didanosine in children with human immunodeficiency virus infection.
- Clinical and pharmacokinetic evaluation of long-term therapy with didanosine in children with HIV infection.
- Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infection.
- Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype.
- Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine.
- In vivo and in vitro characterization of murine T-cell clones reactive to Mycobacterium tuberculosis.
- Genes for the major protein antigens of Mycobacterium tuberculosis: the etiologic agents of tuberculosis and leprosy share an immunodominant antigen.
- Diagnosis of human immunodeficiency virus infection in infants and children.
- Gene replacement and expression of foreign DNA in mycobacteria.
- Pneumocystis carinii pneumonia despite prophylaxis in children with human immunodeficiency virus infection.
- Drug trial benefited HIV children.
- Retinal toxicity in human immunodeficiency virus-infected children treated with 2',3'-dideoxyinosine.
- Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.
- Dideoxyinosine in children with symptomatic human immunodeficiency virus infection.
- Pseudomonas infections in children with human immunodeficiency virus infection.
- Smooth muscle tumors in children with human immunodeficiency virus infection.
- Cerebral artery aneurysms in children infected with human immunodeficiency virus.
- Defining the population of human immunodeficiency virus-infected children at risk for Mycobacterium avium-intracellulare infection.
- Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficie...
- CD4 status and P24 antigenemia. Are they useful predictors of survival in HIV-infected children receiving antiretroviral therapy?
- The use of nucleoside analogues in the treatment of HIV-infected children.
- Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in a child infected with human immunodeficiency virus.
- Combination treatment with azidothymidine and granulocyte colony-stimulating factor in children with human immunodeficiency virus infection.
- RshA, an anti-sigma factor that regulates the activity of the mycobacterial stress response sigma factor SigH.
- Leaving on the lights: host-specific derepression of Mycobacterium tuberculosis gene expression by anti-sigma factor gene mutations.
- The mRNA interferases, MazF-mt3 and MazF-mt7 from Mycobacterium tuberculosis target unique pentad sequences in single-stranded RNA.
- Wag31, a homologue of the cell division protein DivIVA, regulates growth, morphology and polar cell wall synthesis in mycobacteria.
- Nitrile-inducible gene expression in mycobacteria.
- A modified immunoblot method to identify substrates of protein kinases.
- A high-throughput screen identifies a new natural product with broad-spectrum antibacterial activity.
Schools
Harvard Medical School
Children39s Hospital Boston
Doctors Specialties
- Pediatric Infectious Disease Medicine
- Pediatric Infectious Disease
Accepted Insurances
Education
-
Boston Children's Hospital -
Harvard Medical School
Hospital
-
Boston Children's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Virginia M. Pierce, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julia R. Koehler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Courtney A. Gidengil, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keri A. Cohn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Asim A. Ahmed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason B. Harris, MD |
|
|
Dr. Charlotte A. Mao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mythili Aingaran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Silvia S. Chiang, MD
This Doctor is OpenDoctor Recommended.
|